GLP-1 Agonists Linked to Higher Risk for GI Complications GLP-1 Agonists Linked to Higher Risk for GI Complications

Compared with naltrexone/bupropion for weight loss, semaglutide and liraglutide were associated with a higher risk for three adverse gastrointestinal outcomes.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news